Mark Cuban’s drug company to add another branded med

Mark Cuban Cost Plus Drug Co. will sell Euthyrox, its 21st brand-name drug, in March. 

Advertisement

Euthyrox (levothyroxine) is Provell Pharmaceuticals’ FDA-approved treatment for hypothyroidism and pituitary thyrotropin in thyroid cancer patients. Mark Cuban’s drug company also sells brand-name medications from Pfizer, Bayer and Johnson & Johnson. 

The 20 other branded therapies Cost Plus Drugs offers:

  • Advair Diskus (fluticasone/salmeterol)
  • Brenzavvy (bexagliflozin)
  • CaroSpir (spironolactone)
  • Climara (estradiol)
  • Clomid (clomiphene citrate)
  • Dexamethasone Intensol (dexamethasone)
  • Duavee (conjugated estrogens/bazedoxifene)
  • Estring (estradiol)
  • GaviLyte-C (PEG 3350-KCl-Na bicarb-NaCl-Na sulfate)
  • Invokamet (canagliflozin-metformin HCl)
  • Invokamet XR (canagliflozin-metformin HCl)
  • Invokana (canagliflozin)
  • Nitro-Bid (nitroglycerin)
  • Premarin (conjugated estrogens)
  • Premphase (conjugated estrogens/medroxyprogesterone)
  • Prempro (conjugated estrogens/medroxyprogesterone)
  • Promethegan (promethazine HCl)
  • Tirosint (levothyroxine sodium)
  • Yaz (drospirenone/ethinyl estradiol)
  • Yusimry (adalimumab-aqvh)

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.